tetano
Editor, Senior Moderator
Ann Thorac Med
. 2023 Oct-Dec;18(4):167-172.
doi: 10.4103/atm.atm_83_23. Epub 2023 May 16. Algorithmic approach in the management of COVID-19 patients with residual pulmonary symptoms
Albina Guri[SUP] 1 [/SUP], Lauren Groner[SUP] 2 [/SUP], Joanna Escalon[SUP] 2 [/SUP], Anthony Saleh[SUP] 1 [/SUP]
Affiliations
Coronavirus-19 emerged about 3 years ago and has proven to be a devastating disease, crippling communities worldwide and accounting for more than 6.31 million deaths. The true disease burden of COVID-19 will come to light in the upcoming years as we care for COVID-19 survivors with post-COVID-19 syndrome (PCS) with residual long-term symptoms affecting every organ system. Pulmonary fibrosis is the most severe long-term pulmonary manifestation of PCS, and due to the high incidence of COVID-19 infection rates, PCS-pulmonary fibrosis has the potential of becoming the next large-scale respiratory health crisis. To confront the potentially devastating effects of emerging post-COVID-19 pulmonary fibrosis, dedicated research efforts are needed to focus on surveillance, understanding pathophysiologic mechanisms, and most importantly, an algorithmic approach to managing these patients. We have performed a thorough literature review on post-COVID-19 pulmonary symptoms/imaging/physiology and present an algorithmic approach to these patients based on the best available data and extensive clinical experience.
Keywords: Acute respiratory distress syndrome; coronavirus-19; post-COVID-19 syndrome; post-COVID-19 syndrome-pulmonary fibrosis; proposed management of post-COVID pulmonary symptoms.
. 2023 Oct-Dec;18(4):167-172.
doi: 10.4103/atm.atm_83_23. Epub 2023 May 16. Algorithmic approach in the management of COVID-19 patients with residual pulmonary symptoms
Albina Guri[SUP] 1 [/SUP], Lauren Groner[SUP] 2 [/SUP], Joanna Escalon[SUP] 2 [/SUP], Anthony Saleh[SUP] 1 [/SUP]
Affiliations
- PMID: 38058785
- PMCID: PMC10697302
- DOI: 10.4103/atm.atm_83_23
Coronavirus-19 emerged about 3 years ago and has proven to be a devastating disease, crippling communities worldwide and accounting for more than 6.31 million deaths. The true disease burden of COVID-19 will come to light in the upcoming years as we care for COVID-19 survivors with post-COVID-19 syndrome (PCS) with residual long-term symptoms affecting every organ system. Pulmonary fibrosis is the most severe long-term pulmonary manifestation of PCS, and due to the high incidence of COVID-19 infection rates, PCS-pulmonary fibrosis has the potential of becoming the next large-scale respiratory health crisis. To confront the potentially devastating effects of emerging post-COVID-19 pulmonary fibrosis, dedicated research efforts are needed to focus on surveillance, understanding pathophysiologic mechanisms, and most importantly, an algorithmic approach to managing these patients. We have performed a thorough literature review on post-COVID-19 pulmonary symptoms/imaging/physiology and present an algorithmic approach to these patients based on the best available data and extensive clinical experience.
Keywords: Acute respiratory distress syndrome; coronavirus-19; post-COVID-19 syndrome; post-COVID-19 syndrome-pulmonary fibrosis; proposed management of post-COVID pulmonary symptoms.